RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 TAVI with Balloon and Self-expandable Devices: Results from the Milan Registry
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 8
SP 10
OP 11
DO 10.1177/155989771208005
UL http://mdc.sagepub.com/content/12/8/10.abstract
AB Transcatheter aortic valve implantation (TAVI) is a viable treatment option for high-risk surgical patients with severe symptomatic aortic stenosis (AS). The SAPIEN XT™ (SXT) and CoreValve® with AccuTrak™ delivery system (MCVAT) are new generation devices currently available in Europe for transfemoral TAVI. To date, no prospective comparisons between these 2 devices have been undertaken. The objectives of this study were to assess the overall clinical outcomes of TAVI and to compare the SXT versus MCVAT devices in a nonrandomized registry population.